EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Factors Affecting Quality of Life of Thai Cervical Cancer Patients

Kanyarat Katanyoo, Montarat Thavorncharoensap, Thannaporn Kittisiam iD

Journal of Obstetrics and Gynaecology Research · 2026-07 · 52 (7)

DOI: 10.1111/jog.70392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 02.07.2026. Verfasst von Kanyarat Katanyoo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Quality of Life, Uterine Cervical Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Navamindradhiraj University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to assess the quality of life (QoL) among Thai patients with cervical cancer and identify the factors influencing utility scores using the European Organization for the Research and Treatment of Cancer: Quality of Life Questionnaire Core 30 (EORTC QLQ‐C30), EORTC: Cervical Cancer Module 24 (EORTC QLQ‐CX24), and EQ‐5D‐5L instruments.

Methods

This cross‐sectional study was conducted at Vajira Hospital, Thailand, and included 205 patients with cervical cancer. Demographics data, cancer stage, treatment status, and caregiving support, were collected. The participants completed the QoL questionnaires. Multivariate Tobit regression analysis was used to analyze the predictors of EQ‐5D‐5L utility scores.

Results

The mean global QoL score (EORTC QLQ‐C30) and mean utility score (EQ‐5D‐5L) were 73.62 ± 21.57 and 0.90 ± 0.18, respectively. Fatigue was the most frequently reported symptom, whereas sexual dysfunction (EORTC QLQ‐CX24) and emotional distress were common challenges. Patients who had completed treatment without disease reported the highest utility score (mean: 0.96), whereas Stages III–IVA patients under palliative care had the lowest utility score (mean: 0.66). Multivariable analysis revealed that Stage III/IVa, palliative treatment, and having at least one caregiver were independently associated with significantly lower utility scores.

Conclusions

Cervical cancer significantly affects the QoL, with advanced stage and treatment status being major contributors to reduced utility. Additionally, the patient symptom burden is dominated by prominent fatigue and a distinct sexual health profile, characterized by a marked discordance between profoundly low sexual activity and persistent sexual worry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeUterine Cervical NeoplasmsHumansFemaleThailandMiddle AgedCross-Sectional StudiesAdultAgedSurveys and QuestionnairesFatigueSexual Dysfunction, Physiological

Stichwörter der Autor:innen

cervical cancerquality of lifesexual dysfunction

Autor:innen und Institutionen

  • Department of Radiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
  • Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
  • Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.

ORCID-Profile: Thannaporn Kittisiam

Förderung

  • Navamindradhiraj University

Zitieren

APA

Katanyoo, K., Thavorncharoensap, M., & Kittisiam, T. (2026). Factors Affecting Quality of Life of Thai Cervical Cancer Patients. Journal of Obstetrics and Gynaecology Research, 52(7). https://doi.org/10.1111/jog.70392

Vancouver

Katanyoo K, Thavorncharoensap M, Kittisiam T. Factors Affecting Quality of Life of Thai Cervical Cancer Patients. Journal of Obstetrics and Gynaecology Research. 2026;52(7). doi:10.1111/jog.70392

BibTeX
@article{Katanyoo2026,
  author = {Katanyoo, Kanyarat and Thavorncharoensap, Montarat and Kittisiam, Thannaporn},
  title = {Factors Affecting Quality of Life of Thai Cervical Cancer Patients},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2026},
  volume = {52},
  number = {7},
  doi = {10.1111/jog.70392}
}
Kostenlos starten →